| Prevalence of cerebral amyloid pathology in persons without dementia: a meta-analysis WJ Jansen, R Ossenkoppele, DL Knol, BM Tijms, P Scheltens, ... Jama 313 (19), 1924-1938, 2015 | 1592 | 2015 |
| Is Alzheimer's disease a type 3 diabetes? A critical appraisal R Kandimalla, V Thirumala, PH Reddy Biochimica et Biophysica Acta (BBA)-Molecular Basis of Disease 1863 (5 …, 2017 | 681 | 2017 |
| Cancer chemotherapy and beyond: Current status, drug candidates, associated risks and progress in targeted therapeutics U Anand, A Dey, AKS Chandel, R Sanyal, A Mishra, DK Pandey, ... Genes & Diseases 10 (4), 1367-1401, 2023 | 468 | 2023 |
| Dynamics of diabetes and obesity: Epidemiological perspective A Boles, R Kandimalla, PH Reddy Biochimica et Biophysica Acta (BBA)-Molecular Basis of Disease 1863 (5 …, 2017 | 338 | 2017 |
| Protective effects of Indian spice curcumin against amyloid-β in Alzheimer’s disease PH Reddy, M Manczak, X Yin, MC Grady, A Mitchell, S Tonk, CS Kuruva, ... Journal of Alzheimer's Disease 61 (3), 843-866, 2018 | 334 | 2018 |
| Hippocampal mutant APP and amyloid beta-induced cognitive decline, dendritic spine loss, defective autophagy, mitophagy and mitochondrial abnormalities in a mouse model of … M Manczak, R Kandimalla, X Yin, PH Reddy Human molecular genetics 27 (8), 1332-1342, 2018 | 265 | 2018 |
| Therapeutics of neurotransmitters in Alzheimer’s disease R Kandimalla, PH Reddy Journal of Alzheimer's Disease 57 (4), 1049-1069, 2017 | 257 | 2017 |
| Hippocampal phosphorylated tau induced cognitive decline, dendritic spine loss and mitochondrial abnormalities in a mouse model of Alzheimer’s disease R Kandimalla, M Manczak, X Yin, R Wang, PH Reddy Human molecular genetics 27 (1), 30-40, 2018 | 218 | 2018 |
| Protective effects of reduced dynamin-related protein 1 against amyloid beta-induced mitochondrial dysfunction and synaptic damage in Alzheimer’s disease M Manczak, R Kandimalla, D Fry, H Sesaki, PH Reddy Human molecular genetics 25 (23), 5148-5166, 2016 | 187 | 2016 |
| Reduced dynamin-related protein 1 protects against phosphorylated Tau-induced mitochondrial dysfunction and synaptic damage in Alzheimer’s disease R Kandimalla, M Manczak, D Fry, Y Suneetha, H Sesaki, PH Reddy Human molecular genetics 25 (22), 4881-4897, 2016 | 169 | 2016 |
| Withania somnifera (L.) Dunal (Ashwagandha): A comprehensive review on ethnopharmacology, pharmacotherapeutics, biomedicinal and toxicological aspects S Paul, S Chakraborty, U Anand, S Dey, S Nandy, M Ghorai, SC Saha, ... Biomedicine & Pharmacotherapy 143, 112175, 2021 | 167 | 2021 |
| Carbon-based nanomaterials: promising antiviral agents to combat COVID-19 in the microbial-resistant era Á Serrano-Aroca, K Takayama, A Tuñón-Molina, M Seyran, SS Hassan, ... ACS nano 15 (5), 8069-8086, 2021 | 167 | 2021 |
| Understanding aspects of Aluminum exposure in a lzheimer's disease development R Kandimalla, J Vallamkondu, EB Corgiat, KD Gill Brain pathology 26 (2), 139-154, 2016 | 166 | 2016 |
| The structural basis of accelerated host cell entry by SARS‐CoV‐2 M Seyran, K Takayama, VN Uversky, K Lundstrom, G Palù, SP Sherchan, ... The FEBS journal 288 (17), 5010-5020, 2021 | 163 | 2021 |
| Protective effects of a natural product, curcumin, against amyloid β induced mitochondrial and synaptic toxicities in Alzheimer's disease PH Reddy, M Manczak, X Yin, MC Grady, A Mitchell, R Kandimalla, ... Journal of Investigative Medicine 64 (8), 1220-1234, 2016 | 159 | 2016 |
| Mitochondrial division inhibitor 1 reduces dynamin-related protein 1 and mitochondrial fission activity M Manczak, R Kandimalla, X Yin, PH Reddy Human molecular genetics 28 (2), 177-199, 2019 | 157 | 2019 |
| Multiple faces of dynamin-related protein 1 and its role in Alzheimer's disease pathogenesis R Kandimalla, PH Reddy Biochimica et Biophysica Acta (BBA)-Molecular Basis of Disease 1862 (4), 814-828, 2016 | 149 | 2016 |
| A critical evaluation of neuroprotective and neurodegenerative MicroRNAs in Alzheimer's disease PH Reddy, S Tonk, S Kumar, M Vijayan, R Kandimalla, CS Kuruva, ... Biochemical and Biophysical Research Communications 483 (4), 1156-1165, 2017 | 142 | 2017 |
| Prevalence estimates of amyloid abnormality across the Alzheimer disease clinical spectrum WJ Jansen, O Janssen, BM Tijms, SJB Vos, R Ossenkoppele, PJ Visser, ... JAMA neurology 79 (3), 228-243, 2022 | 141 | 2022 |
| Mitochondrial energy metabolism impairment and liver dysfunction following chronic exposure to dichlorvos GKD Binukumar BK, Bal A, Kandimalla R, Sunkaria A Toxicology 270 (2-3), 77-84, 2010 | 137 | 2010 |
Willayat Yousuf WaniNorthwestern University, Feinberg School of MedicineVerified email at northwestern.edu
